Residual renal function assessment with cystatin C

Pediatric Nephrology

Volumn 26, Issue 3, 2011, Pages 333-335

  Filler, Guido ^a,b   Huang, Shih Han S ^a   Lindsay, Robert M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Department of Pediatrics ^*  (Canada)

Author keywords

Cystatin C; End stage renal disease; Hemodialysis; Peritoneal dialysis; Residual renal function; Ultrafiltration

Indexed keywords

CYSTATIN C;

CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CREATININE CLEARANCE; DIALYSATE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MORBIDITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RESIDUAL RENAL FUNCTION; REVIEW;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CREATININE; CYSTATIN C; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; NEPHELOMETRY AND TURBIDIMETRY; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; UREA; URODYNAMICS;

EID: 79954985867     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1672-1     Document Type: Review

References (17)

1. EG Lowrie NM Laird TF Parker JA Sargent 1981 Effect of the hemodialysis prescription of patient morbidity: report from the national cooperative dialysis study New Engl J Med 305 1176 1181 7027040 10.1056/NEJM198111123052003 1:STN:280:DyaL38%2FjsFOntw%3D%3D (Pubitemid 12237476)
2. G Eknoyan GJ Beck AK Cheung JT Daugirdas T Greene JW Kusek M Allon J Bailey JA Delmez TA Depner JT Dwyer AS Levey NW Levin E Milford DB Ornt MV Rocco G Schulman SJ Schwab BP Teehan R Toto Hemodialysis (HEMO) Study Group 2002 Effect of dialysis dose and membrane flux in maintenance hemodialysis N Engl J Med 347 2010 2019 12490682 10.1056/NEJMoa021583 (Pubitemid 35461657)
3. R Paniagua D Amato E Vonesh R Correa-Rotter A Ramos J Moran S Mujais Mexican Nephrology Collaborative Study Group 2002 Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial J Am Soc Nephrol 13 1307 1320 11961019 1:CAS:528:DC%2BD38XktFaitrs%3D (Pubitemid 34441412)
4. JM Bargman KE Thorpe DN Churchill 2001 Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA Study J Am Soc Nephrol 12 2158 2162 11562415 1:STN:280: DC%2BD3MrivV2msg%3D%3D (Pubitemid 32880353)
5. F Termorshuizen FW Dekker JG van Manen JC Korevaar EW Boeschoten RT Krediet 2004 Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 J Am Soc Nephrol 15 1061 1070 15034110 10.1097/01.ASN.0000117976.29592.93 (Pubitemid 38375326)
6. National Kidney Foundation 2006 2006 updates clinical practice guidelines and recommendations. Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access Am J Kidney Dis 48(suppl 1) S1 S322
7. SJ Kim YB Sohn SW Park DK Jin KH Paik 2010 Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis Pediatr Nephrol 10.1007/s00467-010-xxxx-x
8. MP Delaney PE Stevens M Al Hasani HJ Stowe C Judge EJ Lamb 2008 Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study Am J Kidney Dis 51 278 284 18215705 10.1053/j.ajkd.2007.08.018 1:CAS:528:DC%2BD1cXisVOlsbw%3D
9. S Ros A Bajo G del Peso A Garcia de Miguel S Santacruz E Fernandez R de Garcia R Selgas 2007 Cystatin C as marker of residual renal function in patients on peritoneal dialysis: relations with parameters of peritoneal function J Nephrol 20 468 473 17879214 1:CAS:528:DC%2BD2sXhsVygt7zI (Pubitemid 350081502)
10. FJ Hoek JC Korevaar FW Dekker EW Boeschoten RT Krediet 2007 Estimation of residual renal glomerular filtration rate in dialysis patients from the plasma cystatin C level Nephrol Dial Transplant 22 1633 1638 17403704 10.1093/ndt/gfm027 1:CAS:528:DC%2BD2sXot1Sgs7g%3D (Pubitemid 47073762)
11. G Filler A Bökenkamp W Hofmann T Le Bricon C Martínez- Brú A Grubb 2005 Cystatin C as a marker of GFR-history, indications, and future research Clin Biochem 38 1 8 15607309 10.1016/j.clinbiochem.2004.09.025 1:CAS:528:DC%2BD2cXhtVyqsLbN (Pubitemid 39647648)
12. P Evenepoel B Bammens K Verbeke Y Vanrenterghem 2006 Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis Kidney Int 70 794 799 16820785 10.1038/sj.ki.5001640 1:CAS:528:DC%2BD28XnvVyltb8%3D (Pubitemid 44215357)
13. M Jadoul C Garbar R Vanholder J Sennesael C Michel A Robert H Noël C van Ypersele de Strihou 1998 Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients Kidney Int 54 956 959 9734623 10.1046/j.1523-1755.1998.00064.x 1:STN:280:DyaK1cvgtlKqsA%3D%3D (Pubitemid 28397416)
14. N Al-Malki PA Heidenheim G Filler A Yasin RM Lindsay 2009 Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities Clin J Am Soc Nephrol 4 1606 1610 19713293 10.2215/CJN.02910509 1:CAS:528:DC%2BD1MXhtlGgur%2FL
15. AS Sambasivan N Lepage G Filler 2005 Cystatin C intrapatient variability in children with chronic kidney disease is less than serum creatinine Clin Chem 51 2215 2216 16244312 10.1373/clinchem.2005.056150 1:CAS:528: DC%2BD2MXhtFyhtL%2FN (Pubitemid 41532660)
16. RM Lindsay SH Huang G Filler 2010 Cystatin C measurements in the assessment of residual renal function, dialysis adequacy, and beyond Perit Dial Int 30 437 439 20628106 10.3747/pdi.2010.00136
17. LO Hansson 2010 Cystatin C: an emerging marker for pre-timely mortality J Intern Med 268 106 108 20642756 10.1111/j.1365-2796.2010.02238.x